adj.tính từKhông gây tử vong
Phụ đề video
- After a median follow-up of 40.6 months, the incidence of a primary endpoint event, a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or coronary revascularization, was significantly lower in the bempedoic acid group, at 11.7%, than in the placebo group, at 13.3%.
- A key secondary efficacy endpoint event, a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, occurred significantly less often in the bempedoic acid group.